Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
China Yuchai International
CYD
$1.7B
| $6.54M | 0.01% |
504,754
+74,540
| +17% | +$1.03M |
|
1652
AstraZeneca
AZN
$243B
| $6.53M | 0.01% |
73,300
-627,019
| -90% | -$54.4M |
|
|
CHUY
1653
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $6.53M | 0.01% |
263,900
+31,700
| +14% | +$767K |
|
1654
UFP Industries
UFPI
$4.96B
| $6.53M | 0.01% |
163,809
+123,000
| +301% | +$4.78M |
|
|
MOFG
1655
DELISTED
MidWestOne Financial Group
MOFG
| $6.48M | 0.01% |
212,400
+9,300
| +5% | +$273K |
|
1656
Nomad Foods
NOMD
$1.64B
| $6.48M | 0.01% |
316,065
-209,235
| -40% | -$4.46M |
|
|
SPTN
1657
DELISTED
SpartanNash
SPTN
| $6.47M | 0.01% |
547,255
+135,577
| +33% | +$1.53M |
|
1658
Northeast Bank
NBN
$1.15B
| $6.47M | 0.01% |
291,844
+7,099
| +2% | +$151K |
|
1659
Middleby
MIDD
$5.33B
| $6.44M | 0.01% |
55,070
-146,200
| -73% | -$17.9M |
|
1660
IES Holdings
IESC
$15.1B
| $6.43M | 0.01% |
312,532
+37,000
| +13% | +$704K |
|
|
KE
1661
Kimball Electronics
KE
$622M
| $6.43M | 0.01% |
442,858
-40,217
| -8% | -$597K |
|
1662
Diodes
DIOD
$4.77B
| $6.4M | 0.01% |
159,380
-39,771
| -20% | -$1.54M |
|
1663
Lakeland Industries
LAKE
$117M
| $6.36M | 0.01% |
525,092
+15,100
| +3% | +$166K |
|
1664
Bar Harbor Bankshares
BHB
$681M
| $6.34M | 0.01% |
254,450
-4,000
| -2% | -$95.5K |
|
1665
Norfolk Southern
NSC
$75.1B
| $6.34M | 0.01% |
35,300
-288,900
| -89% | -$53.1M |
|
|
AMNB
1666
DELISTED
American National Bankshares Inc
AMNB
| $6.32M | 0.01% |
178,200
+9,760
| +6% | +$347K |
|
1667
Nomura Holdings
NMR
$28.7B
| $6.29M | 0.01% |
1,480,195
+903,095
| +156% | +$3.43M |
|
|
RDUS
1668
DELISTED
Radius Recycling
RDUS
| $6.29M | 0.01% |
304,196
+19,100
| +7% | +$460K |
|
1669
Kilroy Realty
KRC
$4.22B
| $6.26M | 0.01% |
80,400
-132,500
| -62% | -$10.3M |
|
1670
Southern First Bancshares
SFST
$608M
| $6.25M | 0.01% |
156,701
+18,401
| +13% | +$715K |
|
|
GTS
1671
DELISTED
Triple-S Management Corporation
GTS
| $6.23M | 0.01% |
464,966
+73,218
| +19% | +$1.56M |
|
1672
Commerce Bancshares
CBSH
$8.64B
| $6.22M | 0.01% |
144,225
+52,063
| +56% | +$2.17M |
|
1673
Diana Shipping
DSX
$309M
| $6.18M | 0.01% |
2,614,162
+813,004
| +45% | +$1.94M |
|
1674
FormFactor
FORM
$10.3B
| $6.15M | 0.01% |
330,085
+107,917
| +49% | +$1.85M |
|
1675
BCB Bancorp
BCBP
$163M
| $6.15M | 0.01% |
479,076
+18,000
| +4% | +$227K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.